Time to turn the surgical tables, boys. |
||||
Despite new alternatives, last week the House voted to fund expanded embryonic stem cell research with your tax dollars. As the U.S. embraces therapeutic cloning, the shortage of human eggs has scientists and politicians mischaracterizing egg “donation” as a minimally invasive procedure. Jennifer Lahl calls egg donation “reckless endangerment” and doubts there's a man alive who would sign up for the hormone injections and testicular medical machinations (including shots right into the testes!) required for donation. |
||||
| June 12, 2007 | by Jennifer Lahl |
|||
John T. Gill, chairman of the Texas Healthcare Task Force, and Texas GOP Rep. Pete Sessions are promoting embryonic stem cell research by telling everyone they can, including members of Congress, that egg harvesting from women is "a simple, minimally invasive procedure." |
||||
Click below to watch Jennifer Lahl’s congressional briefing from the Washington D.C. conference, “Trading on the Female Body,” held March 8 to discuss egg donation risks. http://cbc-network.org/ |
||||
Nancy Pelosi believes that embryonic stem cell research (which requires the destruction of human embryos) is a gift from God. "Science is a gift of God to all of us, and science has taken us to a place that is biblical in its power to cure," said Nancy Pelosi, a California Democrat and speaker of the House. 'And that is the embryonic stem cell research.'" |
||||
"People have long warned we were moving toward a 'Brave New World,' " said Robert P. George of Princeton University, who serves on the President's Council on Bioethics. "This is just more evidence that we haven't been able to restrain this move towards treating human life like a commodity. This buying and selling of eggs and sperm and now embryos based on IQ points and PhDs and other traits really moves us in the direction of eugenics." washingtopost.com |
||||
Egg "donation" is risky business The current soaring demand for human eggs is stirring up controversy about the range of prices women are able to fetch for undergoing medical processes necessary for egg extraction. A recent New York Times article examined the ethical issues that arise when payments increase enough to entice young women to undergo risks they may not fully understand. Part of the problem is incomplete disclosure of known risks but even more concerning is the lack of rigor in researching both short and long term risks and insuring that all women are fully informed before undergoing the process of hyperstimulation of the ovaries prior to extraction. “There’s no health-outcome data collected by anybody other than some voluntary reporting, and there’s no postmarket testing on how these drugs are being used,” said Susan Berke Fogel, co-founder of the Pro-Choice Alliance for Responsible Research, a project of the Public Health Institute in Oakland, Calif. In a recent article in The New England Journal of Medicine, a Harvard Business School professor said the controversy over the price of eggs was obscuring questions of women’s health. The author, Debora L. Spar, an economist who wrote “The Baby Business” last year, calls for more studies of the drugs being used, more long-term follow-up of donors and federal regulations to ensure proper informed consent." |
||||
|
||||
Send your letter to the editor to feedback@tothesource.org. |
||||
© Copyright 2007 - tothesource |
||||